UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Exploitation of Geometric Data provided by Laser Scanning to Create FEM Structural Models of Bridges

Journal of performance of constructed facilities, 2016-06, Vol.30 (3)

2016

Volltextzugriff (PDF)

Evaluation of historical bridges through recreation of GPR models with the FDTD algorithm

NDT & E international : independent nondestructive testing and evaluation, 2016-01, Vol.77, p.19-27

2016

Volltextzugriff (PDF)

TNF-alpha antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients

Clinical and experimental rheumatology, 2012-11, Vol.30 (6), p.850

2012

Volltextzugriff (PDF)

Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first‐line chemotherapy in routine practice

Annals of oncology, 2018-06, Vol.29, p.v45-v45

2018

Volltextzugriff (PDF)

Perceptual speech coding and enhancement using frame-synchronized fast wavelet packet transform algorithms

IEEE transactions on signal processing, 1999-06, Vol.47 (6), p.1622-1635

1999

Volltextzugriff (PDF)

AUTOMATIC CREATION OF STRUCTURAL MODELS FROM POINT CLOUD DATA: THE CASE OF MASONRY STRUCTURES

ISPRS annals of the photogrammetry, remote sensing and spatial information sciences, 2015-08, Vol.II-3/W5, p.3-9

2015

Volltextzugriff (PDF)

Leptin and visfatin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

Clinical and experimental rheumatology, 2013-07, Vol.31 (4), p.538

2013

Volltextzugriff (PDF)

Adiponectin and resistin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

Clinical and experimental rheumatology, 2013-05, Vol.31 (3), p.365

2013

Volltextzugriff (PDF)

New fluidic model for in vitro testing of vascular effects of drugs: 4D endothelial sensing (4D-ENDOSENS)

Cardiovascular research, 2022-06, Vol.118 (Supplement_1)

2022

Volltextzugriff (PDF)

Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

Clinical and experimental rheumatology, 2013-07, Vol.31 (4), p.532

2013

Volltextzugriff (PDF)

Correlation between two biomarkers of atherosclerosis, osteopontin and angiopoietin-2, in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

Clinical and experimental rheumatology, 2014-03, Vol.32 (2), p.231

2014

Volltextzugriff (PDF)

Gelsolin levels are decreased in ankylosing spondylitis patients undergoing anti-TNF-alpha therapy

Clinical and experimental rheumatology, 2014-03, Vol.32 (2), p.218

2014

Volltextzugriff (PDF)

Correlation between insulin resistance and serum ghrelin in non-diabetic ankylosing spondylitis patients undergoing anti-TNF-α therapy

Clinical and experimental rheumatology, 2013-11, Vol.31 (6), p.913

2013

Volltextzugriff (PDF)

Renal primary angiosarcoma

Clinical & translational oncology, 2007-12, Vol.9 (12), p.806-810

2007

Volltextzugriff (PDF)

P-160Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice

Annals of oncology, 2018-06, Vol.29 (suppl_5)

2018

Volltextzugriff (PDF)

AB1040 Joint Symptoms before Cancer Diagnosis: Observational Study Northwestern Spain

Annals of the rheumatic diseases, 2014-06, Vol.73 (Suppl 2), p.1144-1144

2014

Volltextzugriff (PDF)

1157P Retreatment with peptide receptor radionuclide therapy (PRRT) in patients (p) with neuroendocrine tumors (NET): Spanish clinical experience from SEPTRALU national registry

Annals of oncology, 2024-09, Vol.35, p.S756-S756

2024

Volltextzugriff (PDF)

P-63 Efficacy, safety and prognostic subgroups for outcome with regorafenib in patients with refractory metastatic colorectal cancer in the real-world setting: The CORE study

Annals of oncology, 2022-06, Vol.33, p.S269-S270

2022

Volltextzugriff (PDF)

P-34 Real-world efficacy and safety of immune checkpoint inhibitors in microsatellite unstable or mismatch repair deficient gastrointestinal tumors

Annals of oncology, 2021-07, Vol.32, p.S107

2021

Volltextzugriff (PDF)

Osteoprotegerin correlates with disease activity and endothelial activation in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

Clinical and experimental rheumatology, 2014-09, Vol.32 (5), p.640

2014

Volltextzugriff (PDF)

Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

Clinical and experimental rheumatology, 2013-09, Vol.31 (5), p.749

2013

Volltextzugriff (PDF)

THU0224 Anti-TNF-[alpha] Therapy Reduces Endothelial Cell Activation in Non-Diabetic Ankylosing Spondylitis Patients

Annals of the rheumatic diseases, 2015-06, Vol.74, p.277

2015

Volltextzugriff (PDF)

Integrated speech enhancement and coding in the time-frequency domain

1997 IEEE International Conference on Acoustics, Speech, and Signal Processing, 1997, Vol.2, p.1183-1186 vol.2

1997

Volltextzugriff (PDF)

Gliomatosis Cerebri : diagnóstico y tratamiento con temozolomida, a propósito de un caso

Oncología (Barcelona), 2007, Vol.30 (3), p.41-45

2007

Volltextzugriff (PDF)

1 – 25 von 657

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(634)
Mit Volltextzugriff
(614)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Exploitation of Geometric Data provided by Laser Scanning to Create FEM Structural Models of Bridges

Evaluation of historical bridges through recreation of GPR models with the FDTD algorithm

TNF-alpha antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients

Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first‐line chemotherapy in routine practice

Perceptual speech coding and enhancement using frame-synchronized fast wavelet packet transform algorithms

AUTOMATIC CREATION OF STRUCTURAL MODELS FROM POINT CLOUD DATA: THE CASE OF MASONRY STRUCTURES

Leptin and visfatin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

Adiponectin and resistin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

New fluidic model for in vitro testing of vascular effects of drugs: 4D endothelial sensing (4D-ENDOSENS)

Apelin serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

Correlation between two biomarkers of atherosclerosis, osteopontin and angiopoietin-2, in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

Gelsolin levels are decreased in ankylosing spondylitis patients undergoing anti-TNF-alpha therapy

Correlation between insulin resistance and serum ghrelin in non-diabetic ankylosing spondylitis patients undergoing anti-TNF-α therapy

P-123 Outcomes and predictive factors of regorafenib benefit in patients with metastatic colorectal cancer in a real-life setting

Renal primary angiosarcoma

P-160Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice

AB1040 Joint Symptoms before Cancer Diagnosis: Observational Study Northwestern Spain

1157P Retreatment with peptide receptor radionuclide therapy (PRRT) in patients (p) with neuroendocrine tumors (NET): Spanish clinical experience from SEPTRALU national registry

P-63 Efficacy, safety and prognostic subgroups for outcome with regorafenib in patients with refractory metastatic colorectal cancer in the real-world setting: The CORE study

P-34 Real-world efficacy and safety of immune checkpoint inhibitors in microsatellite unstable or mismatch repair deficient gastrointestinal tumors

Osteoprotegerin correlates with disease activity and endothelial activation in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

Asymmetric dimethylarginine serum levels in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

THU0224 Anti-TNF-[alpha] Therapy Reduces Endothelial Cell Activation in Non-Diabetic Ankylosing Spondylitis Patients

Integrated speech enhancement and coding in the time-frequency domain

Gliomatosis Cerebri : diagnóstico y tratamiento con temozolomida, a propósito de un caso

Suchergebnisse filtern